Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

RUNX2 mutations in cleidocranial dysplasia patients.

Ryoo HM, Kang HY, Lee SK, Lee KE, Kim JW.

Oral Dis. 2010 Jan;16(1):55-60. doi: 10.1111/j.1601-0825.2009.01623.x. Epub 2009 Sep 8.

PMID:
19744171
2.

RUNX2 mutations in Chinese patients with cleidocranial dysplasia.

Li Y, Pan W, Xu W, He N, Chen X, Liu H, Darryl Quarles L, Zhou H, Xiao Z.

Mutagenesis. 2009 Sep;24(5):425-31. doi: 10.1093/mutage/gep025. Epub 2009 Jun 10.

3.

A Runx2 threshold for the cleidocranial dysplasia phenotype.

Lou Y, Javed A, Hussain S, Colby J, Frederick D, Pratap J, Xie R, Gaur T, van Wijnen AJ, Jones SN, Stein GS, Lian JB, Stein JL.

Hum Mol Genet. 2009 Feb 1;18(3):556-68. doi: 10.1093/hmg/ddn383. Epub 2008 Nov 20.

4.

Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles.

Matheny CJ, Speck ME, Cushing PR, Zhou Y, Corpora T, Regan M, Newman M, Roudaia L, Speck CL, Gu TL, Griffey SM, Bushweller JH, Speck NA.

EMBO J. 2007 Feb 21;26(4):1163-75. Epub 2007 Feb 8.

5.

Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2.

Young DW, Hassan MQ, Pratap J, Galindo M, Zaidi SK, Lee SH, Yang X, Xie R, Javed A, Underwood JM, Furcinitti P, Imbalzano AN, Penman S, Nickerson JA, Montecino MA, Lian JB, Stein JL, van Wijnen AJ, Stein GS.

Nature. 2007 Jan 25;445(7126):442-6.

PMID:
17251981
6.

Networks and hubs for the transcriptional control of osteoblastogenesis.

Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, Hassan MQ, Gaur T, Lengner CJ, Young DW.

Rev Endocr Metab Disord. 2006 Jun;7(1-2):1-16. Review.

PMID:
17051438
7.

Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations.

Cunningham ML, Seto ML, Hing AV, Bull MJ, Hopkin RJ, Leppig KA.

Birth Defects Res A Clin Mol Teratol. 2006 Feb;76(2):78-85. Review.

PMID:
16463420
8.

Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype.

Kim HJ, Nam SH, Kim HJ, Park HS, Ryoo HM, Kim SY, Cho TJ, Kim SG, Bae SC, Kim IS, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Choi JY.

J Cell Physiol. 2006 Apr;207(1):114-22.

PMID:
16270353
9.

Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia.

Puppin C, Pellizzari L, Fabbro D, Fogolari F, Tell G, Tessa A, Santorelli FM, Damante G.

J Hum Genet. 2005;50(12):679-83. Epub 2005 Oct 22.

PMID:
16244783
10.

Nomenclature for Runt-related (RUNX) proteins.

van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y, Liu P, Neil JC, Ohki M, Speck N.

Oncogene. 2004 May 24;23(24):4209-10. No abstract available.

PMID:
15156174
11.

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.

Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH.

Lab Invest. 2004 Apr;84(4):479-84.

12.

Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription.

Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, Lian JB, Stein GS.

EMBO J. 2004 Feb 25;23(4):790-9. Epub 2004 Feb 12.

13.

Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts.

Pratap J, Galindo M, Zaidi SK, Vradii D, Bhat BM, Robinson JA, Choi JY, Komori T, Stein JL, Lian JB, Stein GS, van Wijnen AJ.

Cancer Res. 2003 Sep 1;63(17):5357-62.

14.

Functional analysis of RUNX2 mutations in cleidocranial dysplasia: novel insights into genotype-phenotype correlations.

Yoshida T, Kanegane H, Osato M, Yanagida M, Miyawaki T, Ito Y, Shigesada K.

Blood Cells Mol Dis. 2003 Mar-Apr;30(2):184-93.

PMID:
12732182
15.

The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2.

Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM.

J Biol Chem. 2003 Jan 3;278(1):319-26. Epub 2002 Oct 25.

16.

Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations.

Yoshida T, Kanegane H, Osato M, Yanagida M, Miyawaki T, Ito Y, Shigesada K.

Am J Hum Genet. 2002 Oct;71(4):724-38. Epub 2002 Aug 26.

17.

Causal relationship between the loss of RUNX3 expression and gastric cancer.

Li QL, Ito K, Sakakura C, Fukamachi H, Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y.

Cell. 2002 Apr 5;109(1):113-24.

18.

A case of a Japanese patient with cleidocranial dysplasia possessing a mutation of CBFA1 gene.

Sakai N, Hasegawa H, Yamazaki Y, Ui K, Tokunaga K, Hirose R, Uchinuma E, Susami T, Takato T.

J Craniofac Surg. 2002 Jan;13(1):31-4.

PMID:
11886988
19.

Mutations in the RUNX2 gene in patients with cleidocranial dysplasia.

Otto F, Kanegane H, Mundlos S.

Hum Mutat. 2002 Mar;19(3):209-16. Review.

PMID:
11857736
20.

A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene.

Zaidi SK, Javed A, Choi JY, van Wijnen AJ, Stein JL, Lian JB, Stein GS.

J Cell Sci. 2001 Sep;114(Pt 17):3093-102.

Supplemental Content

Support Center